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CLINICAL KNOWLEDGE
General
Title: Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus
Disease (COVID-19) – updated April 6, 2020
Web Address: https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-managementpatients.html
Key Takeaway 1: Asymptomatic Spread - This CDC update reviews the current data on
asymptomatic and pre-symptomatic infection and transmission of SARS-CoV-2. Viral
transmission has been demonstrated in the pre-symptomatic incubation period of infection, but
the exact degree of viral shedding that confers risk of transmission is not yet clear. Risk of
transmission is thought to be greatest when patients are symptomatic since viral shedding is
greatest at the time of symptom onset and declines over the course of several days to weeks. The
proportion of viral transmission in the population due to asymptomatic or pre-symptomatic
infection compared to symptomatic infection is unclear.
Key Takeaway 2: Medication -- use of ACE inhibitors, AR Blockers and NSAIDS - There
are no data to suggest a link between ACE inhibitors or ARBs with worse COVID-19 outcomes.
The American Heart Association (AHA), the Heart Failure Society of America (HFSA), and the
American College of Cardiology (ACC) released a statement recommending continuation of
these drugs for patients already receiving them for heart failure, hypertension, or ischemic heart
disease. Similarly, there are no data to support withholding NSAIDS.
Key Takeway 3: Reinfection - There are no data concerning the possibility of re-infection with
SARS-CoV-2 after recovery from COVID-19. Clinical recovery has been correlated with the
detection of IgM and IgG antibodies which signal the development of immunity. The clinical
effect of that immunity is unclear.
Title: JAMA Viewpoint: The COVID-19 Pandemic in the USA Clinical Update
Web Address: https://jamanetwork.com/journals/jama/fullarticle/2764366
Key Takeaway: This review updates current knowledge about topics such as why case-fatality
rates vary so much by country and demographic variables in the US, the evolving
recommendations about public use of face-masks, if Covid-19 virus transmission is primarily
droplet or aerosolized and when social distancing measures might be lifted. April 6, 2020.
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Therapeutics
Title: Considerations for drug interaction on QTc in Exploratory Covid-19 Treatment
Web Address: https://www.ahajournals.org/doi/pdf/10.1161/CIRCULATIONAHA.120.047521
Key Takeaway: Joint Statement by American Heart Association and American College of
Cardiology. This letter recommends specific monitoring to minimize risk of adverse drug
reaction when using chloroquine-based treatments for Covid-19 infection. April 8, 2020
Title: Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Web Address: https://www.pnas.org/content/early/2020/04/02/2004168117
Key Takeaway: This is a report on the immunologic and clinical endpoints of 10 patients with
severe Covid-19 infection who were treated with convalescent plasma derived from recently
recovered donors. April 6, 2020.

Critical Care
Title: With ventilators running out, doctors say the machines are overused for Covid-19
Web Address:
https://www.statnews.com/2020/04/08/doctors-say-ventilators-overused-for-covid19/?utm_source=STAT+Newsletters&utm_campaign=9eaf99b9bbDaily_Recap&utm_medium=email&utm_term=0_8cab1d7961-9eaf99b9bb-149678261
Key Takeaway: This is an interesting article by a science reporter about the growing uncertainty
of the pulmonary pathophysiology of severe Covid-19 infection and how to best treat it.
Title: High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating
Patients With Coronavirus Disease 2019
Website: https://academic.oup.com/ofid/article/7/3/ofaa102/5810740
Key Takeaway: This case series reports 3 patients with severe COVID-19 who received highdose intravenous immunoglobulin (IVIg) with satisfactory recovery. With no definite effective
treatments for this novel pathogen, based on these observations high-dose IVIg may be
considered for clinical trials or compassionate use in deteriorating patients infected with COVID19 respiratory failure. March 21, 2020

Ob/Gyn
Title: Interim Considerations for Infection Prevention and Control of Coronavirus Disease
2019 (COVID-19) in Inpatient Obstetric Healthcare Settings
Web Address: https://www.cdc.gov/coronavirus/2019-ncov/hcp/inpatient-obstetric-healthcareguidance.html
Key Takeaway: This is an April 4, 2020 update of CDC Guidance related to:
• Visitors and essential support persons to pregnant women who have known or suspected
COVID-19 infection
• Prioritized testing of pregnant women with suspected COVID-19 at admission or who
develop symptoms of COVID-19 during admission
• Testing of infants with suspected COVID-19 and isolation from other healthy infants
• Determination of whether to keep a mother with known or suspected COVID-19 and her
infant together or separated after birth on a case-by-case basis
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HEALTH WORKFORCE
Title: CDC Guidance – Mitigate Health Care Personnel Staffing Shortages
Web address: https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staff-shortages.html
Key Takeaway: Guidance for health care system managers on two topics: (1) Contingency
Capacity Strategies to Mitigate Staffing Shortages and (2) Crisis Capacity Strategies to Mitigate
Staffing Shortages. April 6, 2020
Title: CDC - Strategies to Optimize the Supply of PPE and Equipment
Web address: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html
Key Takeaway: Guidance for health care system managers. April 3, 2020
Title: Interim Additional Guidance for Outpatient and Ambulatory Care Settings:
Responding to Community Transmission of COVID-19 in the United States
Web address: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ambulatory-care-settings.html
Key Takeaway: This guidance addresses how to:
• Minimize disease transmission to patients, healthcare personnel (HCP) and others
• Identify persons with presumptive COVID-19 disease and implement a triage procedure
to assign appropriate levels of care
• Reduce negative impacts on emergency department and hospital bed capacity and
• Maximize the efficiency of personal protective equipment (PPE) utilization across the
community health system while protecting healthcare personnel.
April 7, 2020

Title: American Association of Nurse Attorney’s POSITION ON COVID-19
Web address: https://www.taana.org/resources/positions/covid19-2020.pdf
Key Takeaway: Policy position advocating for Nurses and other Healthcare Professionals
licensed throughout the United States of America with focus on PPE and self-protection of
HCW. April 2, 2020
Title: NEJM Perspective: Ensuring and Sustaining a Pandemic Workforce
Web address: https://www.nejm.org/doi/full/10.1056/NEJMp2006376?query=featured_home
Key Takeaway: GW’s Institute for Health Workforce Equity and others outlining ways to
support and sustain the health workforce: legal/licensing; the role of payers; potential roles for
students, retirees and cross-discipline health care workers; targeted education/reeducation; and
regional relocation to meet workforce needs.
Title: Effectiveness of Surgical and Cotton Masks in Blocking SARS–CoV-2: A Controlled
Comparison in 4 Patients
Website: https://annals.org/aim/fullarticle/2764367/effectiveness-surgical-cotton-masksblocking-sars-cov-2-controlled-comparison
Key takeaway: Surgical masks do not protect the spread of the virus during coughing/Valsalva.
The outside of the mask can be contaminated with virus too.
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EPIDEMIOLOGY and PUBLIC HEALTH INTERVENTIONS
Title: What We Need to Understand About Asymptomatic Carriers
Web address: https://www.propublica.org/article/what-we-need-to-understand-aboutasymptomatic-carriers-if-were-going-to-beat-coronavirus
Key Takeaway: A thoughtful article about the importance of disease control for asymptomatic
carriers of Covid-19.
Title: Respiratory virus shedding in exhaled breath and efficacy of face masks, April 3,
2020
Web address: https://www.nature.com/articles/s41591-020-0843-2
Key Takeaway: A study of 246 individuals with seasonal respiratory virus infections
randomized to wear or not wear a surgical face mask showed that masks can significantly reduce
detection of coronavirus and influenza virus in exhaled breath and may help interrupt virus
transmission.
Title: Is the coronavirus airborne? Experts can’t agree, April 2, 2020
Web address: https://www.nature.com/articles/d41586-020-00974-w
Key Takeaway: A scientific brief posted to its website on March 27 (and updated on March 29,
see below) reports that the World Health Organization said that there is not sufficient evidence to
suggest that SARS-CoV-2 is airborne, except in a handful of medical contexts, such as when
intubating an infected patient. Experts that work on airborne respiratory illnesses and aerosols
say that gathering unequivocal evidence for airborne transmission could take years and cost
lives.
Title: WHO – Modes of Transmission of virus causing Covid-19: Implication for IPC
precaution recommendations, March 29, 2020
Web address: https://www.who.int/publications-detail/modes-of-transmission-of-virus-causingcovid-19-implications-for-ipc-precaution-recommendations
Key Takeaway: This Scientific Brief outlines the position, based on the available evidence, that
WHO continues to recommend droplet and contact precautions for those people caring for
COVID-19 patients. WHO continues to recommend airborne precautions for circumstances and
settings in which aerosol generating procedures and support treatment are performed, according
to risk assessment.
Title: Washington Post - The coronavirus is infecting and killing black Americans at an
alarmingly high rate – April 7, 2020
Web address: https://www.washingtonpost.com/nation/2020/04/07/coronavirus-is-infectingkilling-black-americans-an-alarmingly-high-rate-post-analysis-shows/?arc404=true
Key Takeaway: Report of the alarming trend of excess Covid-19 mortality among African
Americans.
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Title: Hospitalization Rates and Characteristics of Patients Hospitalized with LaboratoryConfirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020
Website: https://www.cdc.gov/mmwr/volumes/69/wr/mm6915e3.htm
Key Takeaway: Updated April 8, 2020 this documents the demographics of persons
hospitalized with Covid-19 infection in the US.
Title: The Coronavirus epidemic curve is already flattening in New York City
Website: https://www.nber.org/papers/w26917
Key takeaway: There appears to be sufficient evidence to conclude that the curve in New York
City is indeed flattening. The purpose of this report is to set forth the evidence for – and against –
this preliminary but potentially important conclusion. Having examined the evidence, we then
inquire: if the curve is indeed flattening, do we know what caused it to level off?

RESOURCES: DECISION-SUPPORT TOOLS, CALCULATORS,
TREATMENT ALGORITHMS
Title: American Association of Medical Colleges – Covid-19 Clinical Guidance Repository
Web address: www.aamc.org/covid19guidance
Key Takeaway: The AAMC COVID-19 Clinical Guidance Repository includes COVID-19
treatment and management guidance from academic medical centers (AMCs) to serve as a
resource for hospitals and clinicians.
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